Showing results (1001-1010 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 1, 2023
Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management OptionsJose M Rubio, Daniel Guinart, John M Kane, et al.CNS Drugs|September 23, 2023
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.CNS Drugs|June 29, 2023
The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in DepressionAlexander L W Smith, Catherine J Harmer, Philip J Cowen, et al.CNS Drugs|March 14, 2026
Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET StudyDavid T Plante, Alyssa Cairns, Logan D Schneider, et al.CNS Drugs|April 30, 2026
Effect of DL-3-n-Butylphthalide on Cerebral Hypoperfusion Due to Atherosclerotic Stenosis: A Multicenter, Double-Blind, Randomized Controlled, Preliminary TrialDawei Chen, Xinxin Chang, Bei Pan, et al.CNS Drugs|March 27, 2026
Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru®, vs an Oil-Based Formulation, Epidyolex®, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I StudyIgor Bendik, Mareike Beck, Anu Manderna, et al.CNS Drugs|April 4, 2026
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort StudyIzanne Roos, Sifat Sharmin, Serkan Ozakbas, et al.CNS Drugs|May 25, 2026
Cannabidiol Use in Developmental and Epileptic Encephalopathies: A Syndrome- and Age-Stratified Systematic Review and Meta-analysisHelen Michaela de Oliveira, Pandoara Eloa Oliveira Fonseca, José Eduardo Trejo Elías, et al.CNS Drugs|September 14, 2007
Subcutaneous interferon-beta-1a : new formulationKate McKeage, Antona J WagstaffPageof 211